Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin [Phase 1]
Phase 1 study evaluating systemic absorption of dimebon when applied as a skin solution in participants with Alzheimer's disease or Huntingt…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 [Phase 2]
A multi-center, randomized, double-blind Phase 2 trial comparing placebo, 5 mg, and 10 mg of E2020 (donepezil) in Alzheimer's disease has co…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) [Phase 1]
Pfizer conducted a Phase 1 pharmacokinetic study in healthy volunteers to compare four modified-release formulations of dimebon (latrepirdin…
-
CLINICAL_TRIALS trial_result · 2009-12-29Clinical Trial Update: Memory Aid for Informed Consent in Alzheimer's Research [NA]
This update describes a National Institute on Aging–sponsored trial evaluating a memory aid to improve informed consent in Alzheimer's disea…
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease [Phase 2]
A Phase 2 dose-ranging study evaluating the efficacy and safety of SB-742457 (idalopirdine) in Alzheimer's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of an investigational Alzheimer's disease drug sponsored by Merck was terminated; no effi…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Mifepristone as Adjunctive Therapy in Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating mifepristone as adjunctive therapy for Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease [Phase 2]
A Phase 2 trial evaluating the effectiveness of a nutritional brain metabolic enhancer for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Gene Therapy for Alzheimer's Disease Clinical Trial [Phase 1]
Phase 1 gene therapy trial for Alzheimer's disease has completed; results from the study are reported.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study [Phase 2]
Phase 2 clinical trial update for Leuprolide (antigonadotropin) in Alzheimer's disease. The ALADDIN VP 104 study has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Memory Impairment Study (Mild Cognitive Impairment Study) [Phase 3]
A Phase 3 memory impairment study (Mild Cognitive Impairment) sponsored by the National Institute on Aging for Alzheimer's disease has compl…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study) [Phase 2, Phase 3]
A multicenter Phase 2/Phase 3 trial evaluating the NSAID naproxen and the COX-2 inhibitor rofecoxib in Alzheimer’s disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) [Phase 2]
A Phase 2 trial of SGS742 for Alzheimer's disease has completed, according to the sponsor Saegis Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation [Phase 2]
The ALADDIN Phase 2 trial evaluating leuprolide as an antigonadotropin for Alzheimer's disease has completed. The sponsor is Voyager Pharmac…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Estrogen Hormone Protocol [Phase 3]
National Institute on Aging sponsored a Phase 3 trial of an estrogen hormone protocol for Alzheimer's disease. The trial status is Completed…
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease [Phase 2]
This document reports the completion of a Phase 2 clinical trial of SK-PC-B70M for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers [Phase 2]
Phase 2 clinical trial update examining brain uptake and safety of an imaging agent in Alzheimer's disease, amnestic mild cognitive impairme…
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease [Phase 4]
Phase 4 trial evaluates memantine for improving functional communication in Alzheimer's disease, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Curcumin in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial of curcumin in patients with mild to moderate Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Alzheimer's Caregiver Communication Study
This clinical trial update notes the completion of the Alzheimer's Caregiver Communication Study (NCT00182988), sponsored by the National In…
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers [Phase 1]
Phase I pharmacokinetic study to estimate how ketoconazole and omeprazole affect the exposure of dimebon in healthy volunteers, including bo…
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease [Phase 1, Phase 2]
This document reports a completed Phase 1/2 safety trial of a glycogen synthase kinase-3 (GSK3) inhibitor for Alzheimer's disease sponsored …
-
CLINICAL_TRIALS trial_result · 2009-10-23Clinical Trial Update: Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid [Phase 1]
A completed Phase 1 trial assessing AstraZeneca's PET imaging ligands [18F]AZD4694 and [11C]AZD2184 for detecting beta-amyloid in Alzheimer'…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease [Phase 1]
A Pfizer-sponsored Phase I trial evaluating a single intravenous dose of PF-04360365 in adults with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers [Phase 2]
Phase 2 study evaluating LY2062430 in subjects with mild-to-moderate Alzheimer's disease and in healthy volunteers has completed; results we…